Abstract
Chemotherapy and immunotherapy are two distinct approaches for the treatment for high-grade gliomas. Used independently, neither is curative. However, if the appropriate chemotherapeutic agent is selected and its administration is timed in conjunction with immunotherapy, a potent synergistic effect may occur, resulting in a more favorable outcome.
Keywords: Immunotherapy, Chemotherapy, Glioblastoma multiforme, Glioma
Letters in Drug Design & Discovery
Title: Synergistic Effect of Immunotherapy and Chemotherapy in Cancers: Perspective in High Grade Glioma Treatment
Volume: 3 Issue: 8
Author(s): Guillermo R. DeAngulo, Wei Sun and Amy B. Heimberger
Affiliation:
Keywords: Immunotherapy, Chemotherapy, Glioblastoma multiforme, Glioma
Abstract: Chemotherapy and immunotherapy are two distinct approaches for the treatment for high-grade gliomas. Used independently, neither is curative. However, if the appropriate chemotherapeutic agent is selected and its administration is timed in conjunction with immunotherapy, a potent synergistic effect may occur, resulting in a more favorable outcome.
Export Options
About this article
Cite this article as:
DeAngulo R. Guillermo, Sun Wei and Heimberger B. Amy, Synergistic Effect of Immunotherapy and Chemotherapy in Cancers: Perspective in High Grade Glioma Treatment, Letters in Drug Design & Discovery 2006; 3 (8) . https://dx.doi.org/10.2174/157018006778194745
DOI https://dx.doi.org/10.2174/157018006778194745 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Delivery and Application of Dietary Polyphenols to Target Organs, Tissues and Intracellular Organelles
Current Drug Metabolism Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics
Current Pharmaceutical Design Anesthetic Cardioprotection in Relation to Mitochondria: Basic Science
Current Pharmaceutical Design Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues
Current Drug Metabolism <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry Mitophagy in Carcinogenesis and Tumour Progression- A New Paradigm with Emerging Importance
Anti-Cancer Agents in Medicinal Chemistry Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors
Current Neuropharmacology Advances in Helper-Dependent Adenoviral Vector Research
Current Gene Therapy Gene Therapy and Biologic Therapy with Interleukin?4
Current Gene Therapy Assessing Activation States in Microglia
CNS & Neurological Disorders - Drug Targets Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastoma
Current Cancer Drug Targets Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry Stem Cells in Brain Tumorigenesis and their Impact on Therapy
Current Stem Cell Research & Therapy Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies
Current Pharmaceutical Design Shaping Tumor Microenvironment for Improving Nanoparticle Delivery
Current Drug Metabolism Therapeutic Use of MicroRNAs in Cancer
Anti-Cancer Agents in Medicinal Chemistry Antagonists of IAP Proteins: Novel Anti-Tumor Agents
Current Medicinal Chemistry Adenoviral Vectors for Cancer Gene Therapy
Current Genomics A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design